Australian biotech company, Cincera Therapeutics Pty Ltd, has launched this week with an AU$7 million venture capital commitment from the Medical Research Commercialisation Fund (MRCF).
The Company has been founded to develop new therapies to target conditions relating to an unhealthy Western diet, including serious and highly prevalent diseases associated with obesity.
The founding scientists of Cincera are Professor Stuart Pitson from the CCB and Associate Professor Bernard Flynn from Monash University’s Institute of Pharmaceutical Sciences (MIPS).
